Navidea Biopharmaceuticals Announces Closing of its Rights Offering and Second Quarter 2022 Earnings Conference Call and Business Update Aug 30, 2022 09:30AM
Navidea Biopharmaceuticals Announces Subscriptions of Approximately $14.2 Million from its Rights Offering Aug 25, 2022 09:16AM
Navidea Biopharmaceuticals Announces Extension of Subscription Period to August 24, 2022 and Updated Terms of its Previously Announced Rights Offering Aug 18, 2022 08:26AM
Navidea Biopharmaceuticals Reports Second Quarter 2022 Financial Results Aug 15, 2022 08:30AM
Navidea Biopharmaceuticals Announces Commencement of Rights Offering Subscription Period and Updated Terms of its Previously Announced Rights Offering Aug 4, 2022 07:30AM


Aug 1, 2022 07:30AM Navidea Biopharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record for the Previously Announced Rights Offering
Jul 20, 2022 08:57AM Navidea Biopharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Jul 11, 2019 07:47AM Maxim Group Starts Navidea Biopharmaceuticals (NAVB) at Buy
Sep 19, 2014 09:31AM Pre-Open Stock Movers 9/19: (CNQR) (DRC) (JBLU) Higher; (ESI) (CRR) (TIBX) Lower (more...)
Sep 18, 2014 06:07PM After-Hours Stock Movers 9/18 (CNQR) (MCP) (JBLU) Higher; (TIBX) (RHT) (ORCL) Lower (more...)